UNIVERSE PHARMACEUTICALS INC (UPC)

KYG9442G1120 - Common Stock

2.59  +0.08 (+3.19%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
47.98M
56.29%		40.14M
-16.34%		32.309M
-19.51%
EBITDA
YoY % growth
14.04M
31.71%		-6.91M
-149.22%		-3.018M
56.32%
EBIT
YoY % growth
13.59M
32.59%		-7.44M
-154.75%		-3.527M
52.60%
Operating Margin
28.32%-18.54%-10.92%
EPS
YoY % growth
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 13.842M
-13.16%		%
Q2 2023
Q2Q % growth		 18.467M
-23.69%		%
Q4 2022
Q2Q % growth		 15.94M
-66.78%		%
Q2 2022
Q2Q % growth		 24.2M
-0.38%		%
Q4 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q2 2019
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A